---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-178993"
form_type: "8-K/A"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2025-08-12T23:59:59+00:00"
generated_at: "2026-05-17T14:29:11.721969+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Kineta acquisition closed; Q1 2025 financials show $1.7M net loss and $13.2M deficit

## Summary
- Cash $304K, total liabilities $14M, stockholders' deficit $13.2M as of March 31, 2025.
- Net loss attributable to Kineta for Q1 2025 was $1.676M vs $10.238M in Q1 2024 on reduced R&D spend.
- Accumulated deficit reached $184.6M; Kineta has going concern warning with insufficient cash for next 12 months.
- Merger consideration includes up to $16.5M initial stock, $6.5M delayed stock, $12M cash (net of exclusivity credits and working capital adjustments).

## SEC filing metadata
- accession: 0001193125-25-178993
- form_type: 8-K/A
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2025-08-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000119312525178993/0001193125-25-178993-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000119312525178993/d67982d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-178993
- JSON: https://secwatch.observer/filing/0001193125-25-178993.json
- Plain text: https://secwatch.observer/filing/0001193125-25-178993.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.